News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
163,831 Results
Type
Article (3557)
Company Profile (11)
Press Release (160263)
Multimedia
Podcasts (7)
Webinars (1)
Section
Business (72368)
Career Advice (74)
Deals (10852)
Drug Delivery (13)
Drug Development (18293)
Employer Resources (10)
FDA (3233)
Job Trends (3627)
News (95681)
Policy (6289)
Tag
2027 BioCapital Standard (1)
2027 Biotech Beach Standard (1)
2027 Genetown Standard (1)
2027 Pharm Country Standard (1)
Academia (258)
Accelerated approval (18)
ADA (6)
Adcomms (2)
Allergies (56)
Alliances (6873)
ALS (55)
Alzheimer's disease (440)
Antibody-drug conjugate (ADC) (153)
Approvals (3580)
Artificial intelligence (130)
ASCO (140)
Autoimmune disease (111)
Automation (11)
Bankruptcy (93)
Belgium (4)
Best Places to Work (3260)
BIO (10)
Biologics (13)
BIOSECURE Act (1)
Biosimilars (42)
BioSpace Insights (7)
Biotechnology (12)
Bispecific (4)
Bladder cancer (93)
Brain cancer (18)
Breast cancer (280)
Cancer (1910)
Cardiovascular disease (168)
Career advice (68)
Career pathing (5)
CAR-T (67)
CDC (5)
CDMO (16)
Celiac Disease (3)
Cell therapy (182)
Cervical cancer (17)
Clinical research (17954)
Collaboration (443)
Commercialization (9)
Company closure (3)
Compensation (225)
Complete response letters (25)
COVID-19 (501)
CRISPR (21)
C-suite (274)
Cystic fibrosis (30)
Data (3262)
Depression (48)
Dermatology (56)
Diabetes (193)
Diagnostics (1729)
Digital health (15)
Diversity (1)
Diversity, equity & inclusion (2)
Drug discovery (51)
Drug pricing (23)
Drug shortages (2)
Duchenne muscular dystrophy (90)
Earnings (57344)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (20492)
Executive appointments (244)
FDA (4723)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (5)
Frontotemporal dementia (13)
Funding (297)
Gene editing (57)
Generative AI (2)
Gene therapy (195)
GLP-1 (241)
Government (595)
Guidances (338)
Healthcare (4105)
Hematology (52)
HIV (43)
Huntington's disease (10)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (26)
Immunology and inflammation (80)
Immuno-oncology (35)
Indications (96)
Infectious disease (603)
Inflammatory bowel disease (64)
Inflation Reduction Act (2)
Influenza (43)
Intellectual property (99)
Interviews (10)
IPO (6824)
IRA (4)
Job creations (507)
Job search strategy (54)
JPM (7)
Kidney cancer (8)
Kidney disease (17)
Labor market (31)
Layoffs (137)
Leadership (4)
Legal (1223)
Licensing (19)
Liver cancer (29)
Longevity (5)
Lung cancer (326)
Lung diease (2)
Lymphoma (180)
Machine learning (6)
Management (3)
Manufacturing (216)
Marketing (4)
MASH (99)
Medical affairs (1)
Medical device (3607)
Medtech (3675)
Mergers & acquisitions (4512)
Metabolic disorders (456)
mRNA (48)
Multiple sclerosis (97)
NASH (7)
Netherlands (8)
Neurodegenerative disease (113)
Neuropsychiatric disorders (27)
Neuroscience (937)
NextGen: Class of 2026 (956)
Non-profit (467)
Now hiring (10)
Obesity (149)
Opinion (22)
Ovarian cancer (65)
Pain (74)
Pancreatic cancer (96)
Parkinson's disease (99)
Partnered (4)
Patents (195)
Patient recruitment (201)
Patient selection (14)
Peanut (22)
People (7757)
Peptides (5)
Pharmaceutical (3)
Pharmacy benefit managers (4)
Phase 1 (4779)
Phase 2 (7740)
Phase 3 (6979)
Pipeline (5696)
Policy (26)
Postmarket research (541)
Preclinical (1519)
Press Release (21)
Prostate cancer (87)
Psychedelics (3)
Radioligand (1)
Radiopharmaceuticals (63)
Rare diseases (331)
Real estate (562)
Recruiting (5)
Regenerative medicine (5)
Regulatory (6158)
Reports (23)
Research institute (234)
Resumes & cover letters (8)
Rett syndrome (35)
RNA editing (4)
RSV (27)
Schizophrenia (72)
Series A (32)
Series B (27)
Sickle cell disease (34)
Special edition (7)
Spinal muscular atrophy (52)
Sponsored (3)
Startups (277)
Stomach cancer (4)
Substance use disorders (6)
Supply chain (14)
Tariffs (8)
The Weekly (7)
Vaccines (267)
Venture capital (17)
Weight loss (91)
Women's health (36)
Worklife (3)
Date
Today (25)
Last 7 days (131)
Last 30 days (557)
Last 365 days (9477)
2026 (7499)
2025 (9313)
2024 (10764)
2023 (12142)
2022 (12703)
2021 (12598)
2020 (11754)
2019 (9095)
2018 (6678)
2017 (8074)
2016 (6135)
2015 (7670)
2014 (5950)
2013 (4357)
2012 (4887)
2011 (5183)
2010 (4663)
Location
Africa (80)
Alabama (45)
Arizona (69)
Arkansas (3)
Asia (9418)
Australia (837)
California (4742)
Canada (1252)
China (396)
Colorado (240)
Connecticut (272)
Delaware (174)
Europe (20706)
Florida (727)
Georgia (218)
Hawaii (1)
Idaho (12)
Illinois (278)
India (19)
Indiana (226)
Iowa (4)
Japan (231)
Kansas (38)
Kentucky (9)
Louisiana (13)
Maine (44)
Maryland (591)
Massachusetts (3367)
Michigan (113)
Minnesota (264)
Missouri (19)
Montana (10)
Nebraska (2)
Nevada (45)
New Hampshire (28)
New Jersey (1809)
New Mexico (3)
New York (1407)
North Carolina (620)
Northern California (2364)
Ohio (89)
Oregon (6)
Pennsylvania (940)
Puerto Rico (12)
Rhode Island (10)
South America (166)
South Carolina (20)
Southern California (2028)
Tennessee (70)
Texas (1113)
United States (17719)
Utah (120)
Virginia (158)
Washington D.C. (18)
Washington State (408)
Wisconsin (18)
Wyoming (2)
163,831 Results for "31".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Vaxcyte Reports Positive Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31, the Company’s 31-Valent Pneumococcal Conjugate Vaccine Candidate
October 5, 2026
·
17 min read
Press Releases
Organon Announces Quarterly Dividend - July 31, 2026
August 2, 2026
·
1 min read
Press Releases
Vaxcyte to Host Webcast and Conference Call to Present Topline Data from OPUS-1, the Pivotal Adult Phase 3 Trial of VAX-31, the Company’s 31-Valent Pneumococcal Conjugate Vaccine Candidate
October 5, 2026
·
2 min read
Press Releases
Definium Therapeutics Announces New Employee Inducement Grants - August 31, 2026
August 31, 2026
·
1 min read
Press Releases
Novo Nordisk A/S - share repurchase programme - August 31, 2026
August 31, 2026
·
2 min read
Press Releases
Pharma-Bio Serv Announces Results for the Quarter Ended July 31, 2026
September 14, 2026
·
2 min read
Press Releases
MitoRx Therapeutics Appoints Clinical & Scientific Advisory Board to Guide the Development of MTRX31
September 15, 2026
·
7 min read
Press Releases
Satellos to Present at the 31st Annual Congress of the World Muscle Society
September 15, 2026
·
7 min read
Press Releases
Zealand Pharma - Transactions related to share buy-back program (week 31, 2026)
August 3, 2026
·
3 min read
Press Releases
RealTime Laboratories Launches 31-Marker Mycotoxin Extensive Panel, the Most Comprehensive Urinary Mycotoxin Test on the Market
September 22, 2026
·
4 min read
1 of 16,384
Next
